Satsuma Pharmaceuticals
Presence
Satsuma Pharmaceuticals is a company listed under the stock ticker STSA (US).
Acquisition, funding and merger involving Satsuma Pharmaceuticals.
- Shin Nippon Biomedical Laboratories has announced the acquisition of Satsuma Pharmaceuticals (posted on April 18 2023).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Satsuma Pharmaceuticals
- Ryoichi Nagata, President, Chief Executive Officer and Director
- Akihisa Mori, Board Member
- Shu-Ichi Kanazashi, Board Member
Create your alert
to follow the executive moves at Satsuma Pharmaceuticals.
Pharmaceuticals
Satsuma Pharmaceuticals has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Satsuma Pharmaceuticals
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- Satsuma Pharmaceuticals, Inc. - Press Releases
- View more press releases Close
Social media about Satsuma Pharmaceuticals
- Satsuma Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Satsuma Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mic Iwashima 
Call Satsuma Pharmaceuticals at +1 650...
